• Patient a year old man with RAEB

  2019-05-07

  

  Patient 2, a 54-year-old man with RAEB 2, and severe chronic obstructive pulmonary disease, struggled through induction chemotherapy with daunorubicin plus cytarabine (DA) 3+10. Second DA 3+8 produced delayed hematopoietic recovery. CR1 was documented after course 1 and lasted 18 months. Relapse was

• br Authorship br Conflict of interest

  2019-05-07

  

  Authorship Conflict of interest Acknowledgments The Leukemia & Lymphoma Society supported CRC with a Scholar in Clinical Research award (2400-13). This work was supported by the Gatorade Trust from the University of Florida Department of Medicine. Introduction Klinefelter syndrome (KS),

• thymidylate synthase inhibitor The re treatment of metastati

  2019-05-07

  

  The re-treatment of metastatic bone disease causing recurrent pain after an initial course of EBRT was seen to be feasible with a reasonable rate of symptom relief [13–19]. In echoing the ACR findings, the task force noted that the available data was derived from studies where re-treatment was not t

• Preference for injectable therapy over oral therapy

  2019-05-07

  

  Preference for injectable therapy over oral therapy [17], contrary to our findings from a previous study [18], could reflect the fact that most patients have not received an oral bone-targeted agent for metastatic disease. However, the practical advantages of an injectable therapy and the lack of ne

• Introduction Metastasis to the bone is a common complication

  2019-05-07

  

  Introduction Metastasis to the bone is a common complication of breast, lung, prostate, gastrointestinal, haematological, melanoma, and other tumours [1–3]. In many patients with primary breast, prostate and lung primary tumours, bone metastases (BoM) are signs associated with the presence of disse

• br Methods br Results br Discussion

  2019-05-06

  

  Methods Results Discussion The results of this study demonstrate that (1) low-dose landiolol (0.5μgkg−1min−1) prevent heart rate elevation after AF ablation; (2) prophylactic administration of low-dose landiolol successfully prevented immediate AF recurrence within 3d after AF ablation with

• Based on our subgrouping according to ECG patterns

  2019-05-06

  

  Based on our subgrouping according to ECG patterns, men were predominant in the Br, ER, or Br–ER group compared with the true IVF group (Table 1). This sex difference was also noted in previous reports [15–17] and may be partially due to different levels of Ito channel expression between sexes [18].

• tnf alpha inhibitors The presence of an inflammatory infiltr

  2019-05-06

  

  The presence of an inflammatory infiltrate is associated with poor prognosis in a number of malignancies, including those with a predilection for metastasis to bone. CAFs are capable of promoting, and maintaining an inflammatory environment by recruiting immune cells; in particular monocyte/macropha

• Data for each assessment point are

  2019-05-06

  

  Data for each assessment point are expressed as the mean value plus standard deviation. One tailed paired t-tests were performed to analyze the effects of ibandronate treatment. Significance level was set at p Results The study included 33 patients with a variety of different primary tumors (Table

• c-Myc tag Nevertheless we believe that the main

  2019-05-06

  

  Nevertheless, we believe that the main findings of our study are robust. We noted a progressive increase in the prevalence of rheumatic c-Myc tag disease with advancing age of children, modelling different prevalence patterns across age groups separately for each study, and pooling estimates within

• bepridil Azacitidine was administered at a dose of

  2019-05-05

  

  Azacitidine was administered at a dose of 75mg/m2/daily subcutaneously for 7 consecutive days every 28days. Transient neutropenia was observed until the seventh bepridil of the azacitidine treatment was completed. A gradual increase in his blood cell count was noted and the patient eventually became

• br As the global burden of disease shifts from

  2019-05-05

  

  As the global burden of disease shifts from infectious diseases to non-communicable diseases (NCDs), cancer has increasingly become a major contributor to morbidity and mortality in low-income and middle-income countries (LMICs). Major reasons for these mtor pathway shifts include increasing life

• hedgehog pathway One of the unheralded developments

  2019-05-05

  

  One of the unheralded developments in global health is the welcome increase in the number of older people (ie, aged 60 or 65 years and older) in low-income and middle-income countries. In parallel with the gains from this longevity dividend, ageing presents particular challenges to health services.

• ECG changes emerged when creating a

  2019-05-05

  

  ECG changes emerged when creating a substrate map of the LV (Fig. 2A), near the inferior mitral valve. A long transseptal sheath was introduced into the LV under intracardiac echocardiography guidance without causing an air-embolism. While performing the LV substrate mapping, the long transseptal sh

• Recent studies have analyzed the miRNA profile of serum

  2019-05-05

  

  Recent studies have analyzed the miRNA profile of serum and bile samples from patients with PSC and patients with CCA complicating PSC. Overall, the miRNA expression of all analyzed miRNAs from both patients with PSC and patients with CCA complicating PSC was significantly higher compared with healt

15276 records 1009/1019 page Previous Next First page 上5页 10061007100810091010 下5页 Last page